The commentary critically evaluates the paper by Caneque et al., titled "Activation of lysosomal iron triggers ferroptosis in cancer," published in Nature (2025). This study proposes a novel mechanistic model in which lysosomal iron activation serves as the initiating event in ferroptosis, a form of regulated cell death driven by iron-dependent lipid peroxidation. While the concept is intriguing, this commentary highlights several critical weaknesses in the experimental design, methodological rigor, and mechanistic interpretation presented by the authors. The commentary systematically dissects the evidence presented by Caneque et al., particularly their reliance on iron-sensitive fluorescent probes and imaging techniques that lack sufficient specificity and temporal resolution. The authors assert that lysosomal iron mobilization is a key driver of ferroptosis, but the commentary points out that much of the data could also be interpreted as downstream effects of oxidative stress, rather than direct triggers of ferroptosis. The analysis also examines the experimental setup, noting issues with the use of cell line models, genetic perturbations, and controls, as well as concerns over the off-target effects of pharmacological agents used to modulate ferroptosis. Through a detailed figure-by-figure critique, the commentary questions the validity of the claims made in the original study, particularly the centrality of lysosomal iron in the ferroptotic cascade. The commentary also highlights gaps in the understanding of how lysosomal iron dynamics fit into the broader landscape of ferroptosis research, which traditionally focuses on mitochondria and lipid peroxidation. Furthermore, the discussion emphasizes the lack of consideration for other forms of cell death, such as necroptosis and autophagic stress, which could confound the interpretation of the data. In conclusion, this commentary argues that while the hypothesis of lysosomal iron as a trigger for ferroptosis is compelling, the evidence presented by Caneque et al. falls short of establishing a causal link. The commentary provides recommendations for future research, including more rigorous experimental controls, improved measurement techniques, and the need for systems-level approaches to fully understand the role of lysosomal iron in ferroptosis and its potential therapeutic implications in cancer.